Page last updated: 2024-11-04

sulfisoxazole and Pulmonary Fibrosis

sulfisoxazole has been researched along with Pulmonary Fibrosis in 2 studies

Sulfisoxazole: A short-acting sulfonamide antibacterial with activity against a wide range of gram- negative and gram-positive organisms.
sulfisoxazole : A sulfonamide antibacterial with an oxazole substituent. It has antibiotic activity against a wide range of gram-negative and gram-positive organisms.

Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.

Research Excerpts

ExcerptRelevanceReference
"Infants with untreated chlamydial pneumonia shed Chlamydia trachomatis and are symptomatic for may weeks."1.26Treatment of chlamydial pneumonia of infancy. ( Beem, MO; Saxon, E; Tipple, MA, 1979)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Couvreur, J1
Garcia, J1
Tournier, G1
Beem, MO1
Saxon, E1
Tipple, MA1

Other Studies

2 other studies available for sulfisoxazole and Pulmonary Fibrosis

ArticleYear
[Chlamydia trachomatis pneumopathies in infants].
    Revue francaise de gynecologie et d'obstetrique, 1984, Volume: 79, Issue:10

    Topics: Antibodies, Bacterial; Chlamydia Infections; Chlamydia trachomatis; Drug Therapy, Combination; Eryth

1984
Treatment of chlamydial pneumonia of infancy.
    Pediatrics, 1979, Volume: 63, Issue:2

    Topics: Chlamydia trachomatis; Chlamydiaceae Infections; Erythromycin; Humans; Infant; Infant, Newborn; Leng

1979